Abstract
With the spectacular advances in the characterization of genes associated with brain tumors and other neurological disorders, experimental approaches to stably introduce and express foreign genes in vivo have recently evolved as an important tool to study the specific pathogenetic role of candidate genes. A well-characterized and frequently used model are transgenic mice (Wagner 1990; Hanahan 1989; Pattengale et al. 1989). These animals are generated by introduction of DNA constructs into fertilized eggs or into embryonic stem cells. They carry copies of the transgene in all somatic and germ cells and stably transmit the gene to their offspring in a Mendelian fashion. Transcription of the transgene is critically dependent on regulatory sequences. Using specific promoter elements, it is possible to achieve cell- and tissue-specific expression. Cross-breeding of transgenic lines which carry distinct transgenes allows to study the combined effects of the respective genes in vivo.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aguzzi A, Wiestler OD, Kleihues P (1988) Differentiation in the medulloblastoma: an immunohistochemical evaluation of 247 cases from the therapy trial SIOP/GPO MED 84. Verh Dtsch Ges Path 72: 284–287
Aguzzi A, Kleihues P, Heckl K, Wiestler OD (1991) Cell type-specific tumor induction in neural transplants by retrovirus-mediated oncogene transfer. Oncogene 6: 113–118
Armentano D, Thompson AR, Darlington G, Woo SLC (1990) Expression of human factor IX in rabbit hepatocytes by retrovirus-mediated gene transfer: potential for gene therapy of hemophilia B. Proc Natl Acad Sci USA 87: 6141–6145
Barr E, Leiden JM (1991) Systemic delivery of recombinant proteins by genetically modified myoblasts. Science 254: 1507–1509
Bergsagel DJ, Finegold MJ, Butel S, Kupsky WJ, Garcea RL (1992) DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med 326: 988–993
Brinster RL, Chen HY, Messing A, van Dyke T, Levine AJ, Palmiter R (1984) Transgenic mice harboring S V40 T antigen genes develop characteristic brain tumors. Cell 37: 367–379
Brüstle O, Aguzzi A, Talarico D, Basilico C, Kleihues P, Wiestler OD (1992) Angiogenic activity of the K-fgf/hst oncogene in neural transplants. Oncogene 7: 1177–1183
Brüstle O, Petersen I, Radner H, Höll T, Plate KH, Kleihues P, Wiestler OD (1993) Complementary tumor induction in neural grafts exposed to N-ethyl-N-nitrosourea and an activated myc gene. Carcinogenesis 14: 1715–1718
Burger PC, Shibata T, Aguzzi, A, Kleihues P (1988) Selective induction by N-nitrosoethylurea of oligodendrogliomas in fetal forebrain transplants. Cancer Res 48: 2871–2875
Cone RD, Mulligan RC (1984) High efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host range. Proc Natl Acad Sci USA 81: 6349–6353
DeCaprio JA, Ludlow JW, Figge J, Shew J-Y, Huang C-M, Lee W-H, Marsilio E, Paucha E, Livingston DM (1988) SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54: 275–283
Delli-Bovi P, Curatola AM, Kern FG, Greco A, Ittmann M, Basilico C (1987) An oncogene isolated by transfection of Kaposi’ s sarcoma DNA encodes a growth factor that is a member of the FGF family. Cell 50: 729–737
Dhawan J, Pan LC, Pavlath GK, Travis MA, Lanctot AM, Blau HM (1991) Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science 254: 1509–1512
Druckrey H, Ivankovic S, Preussmann R (1966) Teratogenic and carcinogenic effects in the offspring after a single injection of ethylnitrosourea to pregnant rats. Nature 210: 1378–1379
Dyson N, Howley PM, Munger K, Harlow E (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934–937
Fisher U, Jinnah HA, Kale LC, Higgins GA, Gage FH (1991) Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce L-Dopa. Neuron 6: 371–380
Flowers MED, Stockschlaeder MAR, Schuening FG, Niederwieser D, Hackman R, Miller AD, Storb R (1990) Long-term transplantation of canine keratinocytes made resistant to G418 through retrovirus-mediated gene transfer. Proc Natl Acad Sci USA 87: 2349–2353
Friedmann T (1989) Progress toward human gene therapy. Science 244: 1275–1281
Gage FH, Fisher, LJ (1991) Intracerebral grafting: a tool for the neurobiologist. Neuron 6: 1–12
Grussenmeyer T, Scheidtmann KH, Hutchinson MA, Eckhart W, Walter G (1985) Complexes of polyoma virus medium T antigen and cellular proteins. Proc Natl Acad Sci USA 82: 7952–7954
Hanahan D (1989) Transgenic mice as probes into complex systems. Science 246: 1265–1275
Hunter T (1991) Cooperation between oncogenes. Cell 64: 249–270
Land H, Parada LF, Weinberg RA (1983) Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304: 596–602
Ludlow JW, DeCaprio JA, Huang C-M, Lee W-H, Paucha E, Livingston DM (1989) SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell 56: 57–65
Mann R, Mulligan RC, Baltimore D (1983) Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33: 153–159
Marics I, Adelaide J, Raybaud F, Mattei M-G, Coulier F, Planche J, de Lapeyriere O, Birnbaum D (1989) Characterization of the HST-related FGF.6 gene, a new member of the fibroblast growth factor family. Oncogene 4: 335–340
Markowitz D, Goff S, Bank A (1988) A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol 62: 1120–1124
Miller AD (1990) Progress toward human gene therapy. Blood 76: 271–278
Pattengale PK, Stewart TA, Leder A, Sinn E, Muller W, Tepler I, Schmidt E, Leder P (1989) Animal models of human disease. Pathology and molecular biology of spontaneous neoplasms occuring in transgenic mice carrying and expressing activated cellular oncogenes. Am J Pathol 135: 39–61
Sakamoto H, Mori M, Taira M, Yoshida T, Matsukawa S, Shimizu K, Sekiguchi M, Terada M, Sugimura T (1986) Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa. Proc Natl Acad Sci USA. 83: 3997–4001
Stuhlmann H, Cone R, Mulligan RC, Jaenisch R (1984) Introduction of a selectable gene into different animal tissue by a retrovirus recombinant vector. Proc Natl Acad Sci USA 81: 7151–7155
Talarico D, Basilico C (1991) The K-fgf/hst oncogene induces transformation through an autocrine mechanism that requires extracellular stimulation of the mitogenic pathway. Mol Cell Biol 11: 1138–1145
Theuring F, Götz W, Balling R, Korf H-W, Schulze F, Herken R, Gruss P (1990) Tumorigenesis and eye abnormalities in transgenic mice expressing MSV-SV40 large T-antigen. Oncogene 5: 225–232
Thompson TC, Southgate J, Kitchener G, Land H (1989) Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. Cell 56: 917–930
Wagner EF (1990) On transfering genes into stem cells and mice. EMBO J 9: 3025–3032
Whyte P, Williamson NM, Harlow E (1989) Cellular targets for transformation by the adenovirus El A proteins. Cell 56: 67–75
Wiestler OD, Aguzzi A, Schneemann M, Eibl R, von Deimling A, Kleihues P (1992) Oncogene complementation in fetal brain transplants. Cancer Res 52: 3760–3767
Wiestler OD, Brüstle O, Eibl RH, Radner H, Aguzzi A, Kleihues P (1992a) Retrovirus-mediated oncogene transfer into neural transplants. Brain Pathol 2: 47–59
Wiestler OD, Brüstle O, Eibl RH, Radner H, von Deimling A, Plate K, Aguzzi A, Kleihues P (1992b) A new approach to the molecular basis of neoplastic transformation in the brain. Neuropathol Appl Neurobiol 18: 443–453
Williams RL, Courtneidge SA, Wagner EF (1988) Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma middle T oncogene. Cell 52: 121–131
Wright C, Hogan B (1991) Another hit for gene targeting. Nature 350: 458–459
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Wiestler, O.D., Brüstle, O., Eibl, R.H., Radner, H., Aguzzi, A., Kleihues, P. (1994). Oncogene Transfer into the Brain. In: Wiestler, O.D., Schlegel, U., Schramm, J. (eds) Molecular Neuro-oncology and Its Impact on the Clinical Management of Brain Tumors. Recent Results in Cancer Research, vol 135. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85039-4_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-85039-4_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-85041-7
Online ISBN: 978-3-642-85039-4
eBook Packages: Springer Book Archive